. Abstract Submission

Abstract submission closed on May 30.

Each registered participant will be allowed to participate in one mini course and send up to two abstracts, provided the registered participant is the author or co-author of the work. There is no restriction to the number of abstracts one can co-author.

Abstracts must report conclusive results. It will not be possible to include illustrations, graphics and figures in the abstracts. All the works will be presented as posters, although very short oral presentations at posters sessions may be organized.
Although abstracts will be accepted in Portuguese or English, due to the international character of the venue the use of English is being strongly recommended.

Abstracts must be divided into Introduction, Methods, Results and Discussion sessions, and submitted into one of the following topics:

- Agronomy
- Botany / Ethnobotany
- Ethnopharmacology
- Public Health
- Natural Products Chemistry

- Pharmacology / Toxicology (pre-clinical studies and clinical research)
- Pharmacy technology (quality control, pharmacognosy and pharmacothecnics)
- Registration, legislation and patents

Abstract Format
Characters Number = 2400 (including spaces title, authors, affiliation, and acknowledgments).
Title: Use capital letters only at the beginning of the title, acronym, or proper names. Plant names must be italicized.
Authors: Indicating affiliation for each cited author.
References: cite (direct in the text) authors, journal in abbreviated form, volume, initial page and year.
Financial Support and acknowledgments: should be included at the end.


Congress secretariat / information:


Phone: (011) 3361 3056
Fax: (011) 3361 3089
plantasmedicinais@eventus.com.br

Organized by: Centro Brasileiro de Informações sobre Drogas psicotrópicasInternational Society of Ethnopharmacology

 

 

Support:Sociedade Brasileira de Plantas Medicinais Universidade Federal de São Paulo

Universidade Federal do Rio Grande do SulSão Paulo Conventions & Visitor Bureau

Sponsorship:

FEBRAFARMAPfizerAcheBayerNovartisQuimer
SINDUSFARMA